CTI Life Sciences Fund Fund IV

CTI Life Sciences Fund

cb Email

Status

ACTIVE

Global HQ

Montreal, Canada

Countries of investment

Canada
United States

Investment stages

Series A
Series B
Series C

Industries

Biotech
Healthcare

About
CTI Life Sciences is a Montreal-based venture capital firm that invests in promising life sciences companies. They support biotech and medtech innovators from pre-clinical to clinical stages in both Canada and the U.S., aiming to build a diversified portfolio and provide hands-on support to create value.

Min check size: $5.8M
Max check size: $23.4M
Fund size: Unlock
NPS: Unlock

Investment Thesis

CTI Life Sciences is a cross-border venture capital firm investing in high-quality emerging life sciences companies in Canada and the United States. They focus on both biotechnology and medtech sectors, from the pre-clinical stage through to clinical development and early revenue generation. The firm differentiates itself through a hands-on, collaborative approach, leveraging its team's deep scientific, operational, and financial expertise to build a balanced and diversified portfolio.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

The management team comprises seasoned professionals with PhDs and MBAs, bringing over 70 years of combined experience in pharmaceutical R&D, life sciences, and venture capital. Key partners have held senior roles at major pharmaceutical and biotech companies like Vertex Pharmaceuticals, as well as in other venture capital firms like the Business Development Bank of Canada (BDC). Their expertise spans the entire drug development lifecycle, from pre-clinical research to clinical development and commercialization.